Page last updated: 2024-08-24

chloroquine diphosphate and Coronavirus Infections

chloroquine diphosphate has been researched along with Coronavirus Infections in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (7.14)	29.6817
2010's	0 (0.00)	24.3611
2020's	13 (92.86)	2.80

Authors

Authors	Studies
Gao, J; Tian, Z; Yang, X	1
Li, J; Qi, C; Shen, L; Wang, Y; Zhang, Q	1
Wang, Y; Zhu, LQ	1
Bradley, SM; Fihn, SD; Perencevich, E	1
Albuquerque, BC; Alexandre, MAA; Baía-da-Silva, D; Balieiro, AAS; Bassat, Q; Borba, MGS; Brito, M; Brito-Sousa, JD; Croda, J; Daniel-Ribeiro, CT; Fontes, CJ; Guerra, MVF; Hajjar, LA; Lacerda, MVG; Melo, GC; Monteiro, WM; Mourão, MPG; Naveca, FG; Nogueira, ML; Pacheco, AGF; Pinto, RC; Romero, GAS; Sampaio, VS; Santos, JDO; Schwarzbold, A; Siqueira, AM; Val, FFA; Xavier, MS	1
Ahmad, SI	1
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A	1
Almasri, H; Ata, F; Sajid, J; Yousaf, Z	1
Cai, C; Deng, Y; Hu, ZY; Huang, K; Huang, Y; Wang, X; Wang, Y; Xie, J; Xie, Y; Xu, D; Zang, J; Zhan, T; Zheng, F	1
Han, YJ; Ji, XY; Li, XX; Ma, CY; Ren, ZG; Wu, DD; Yan, JL	1
Mo, L; Zheng, P	1
Alshaeri, HK; Natto, ZS	1
Keyaerts, E; Li, S; Maes, P; Rysman, E; Van Ranst, M; Verbeeck, J; Vijgen, L	1

Reviews

5 review(s) available for chloroquine diphosphate and Coronavirus Infections

Article	Year
Clinical trial analysis of 2019-nCoV therapy registered in China. Journal of medical virology, 2020, Volume: 92, Issue:6 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Disease Management; Disease Outbreaks; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Pyrazines; SARS-CoV-2	2020
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019. World journal of pediatrics : WJP, 2020, Volume: 16, Issue:3 Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome	2020
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome	2020
Advances and challenges in the prevention and treatment of COVID-19. International journal of medical sciences, 2020, Volume: 17, Issue:12 Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Chloroquine; Chlorpromazine; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclophilins; Drug Development; Drug Repositioning; Drugs, Chinese Herbal; Endocytosis; Humans; Immune Sera; Interferon Inducers; Nucleic Acid Synthesis Inhibitors; Pandemics; Pneumonia, Viral; Pyrazines; Resveratrol; SARS-CoV-2; Viral Vaccines	2020
A contemporary look at COVID-19 medications: available and potentially effective drugs. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Imatinib Mesylate; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020

Trials

2 trial(s) available for chloroquine diphosphate and Coronavirus Infections

Article	Year
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA network open, 2020, 04-24, Volume: 3, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Chloroquine; Coronavirus Infections; COVID-19; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tertiary Care Centers	2020
[Chloroquine phosphate: therapeutic drug for COVID-19]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2020, Apr-30, Volume: 40, Issue:4 Topics: Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020

Article

Year

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.

JAMA network open, 2020, 04-24, Volume: 3, Issue:4

Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Chloroquine; Coronavirus Infections; COVID-19; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tertiary Care Centers

2020

[Chloroquine phosphate: therapeutic drug for COVID-19].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2020, Apr-30, Volume: 40, Issue:4

Topics: Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020

Other Studies

7 other study(ies) available for chloroquine diphosphate and Coronavirus Infections

Article	Year
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience trends, 2020, Mar-16, Volume: 14, Issue:1 Topics: Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Multicenter Studies as Topic; Pneumonia, Viral; SARS-CoV-2	2020
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2020, Mar-12, Volume: 43, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; China; Chloroquine; Consensus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Humans; Length of Stay; Pneumonia, Viral; Practice Guidelines as Topic	2020
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019. JAMA network open, 2020, 04-24, Volume: 3, Issue:4 Topics: Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection. Medical hypotheses, 2020, Volume: 142 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deoxyribonucleosides; Deoxyribose; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Inflammation; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
COVID-19 presenting with diarrhoea and hyponatraemia. BMJ case reports, 2020, Jun-07, Volume: 13, Issue:6 Topics: Abdominal Pain; Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Darunavir; Diagnosis, Differential; Diarrhea; Humans; Hyponatremia; Male; Pandemics; Pneumonia, Viral; Ribavirin; SARS-CoV-2; Treatment Outcome	2020
Treatment strategies of hospitalized patients with coronavirus disease-19. Aging, 2020, 06-17, Volume: 12, Issue:12 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Female; gamma-Globulins; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Indoles; Interferons; Lopinavir; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2	2020
Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Animals; Animals, Newborn; Antiviral Agents; Cell Line, Tumor; Cell Survival; Chloroquine; Coronavirus Infections; Coronavirus OC43, Human; Female; Humans; Male; Mice; Mice, Inbred C57BL; Milk; Placenta; Pregnancy; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Virus Replication	2009